Biogen Inc’s recently made public that its Head of Development Singhal Priya unloaded Company’s shares for reported $88019.0 on Sep 03 ’24. In the deal valued at $204.22 per share,431 shares were sold. As a result of this transaction, Singhal Priya now holds 5,316 shares worth roughly $0.98 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Singhal Priya bought 431 shares, generating $88,019 in total proceeds.
Before that, Singhal Priya sold 93 shares. Biogen Inc shares valued at $19,817 were divested by the Head of Development at a price of $213.09 per share. As a result of the transaction, Singhal Priya now holds 4,886 shares, worth roughly $0.9 million.
A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in mid February has reiterated a ‘”a Buy”‘ rating for it. Wells Fargo also remained covering BIIB and has decreased its forecast on February 14, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating. UBS revised its rating on January 24, 2024. It rated BIIB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of BIIB
On Tuesday, Biogen Inc [NASDAQ:BIIB] saw its stock fall -0.83% to $183.47. Over the last five days, the stock has lost -1.31%. Biogen Inc shares have fallen nearly -29.10% since the year began. Nevertheless, the stocks have fallen -21.77% over the past one year. While a 52-week high of $268.30 was reached on 01/03/24, a 52-week low of $181.24 was recorded on 10/25/24. SMA at 50 days reached $194.44, while 200 days put it at $214.86.
Levels Of Support And Resistance For BIIB Stock
The 24-hour chart illustrates a support level at 182.01, which if violated will result in even more drops to 180.56. On the upside, there is a resistance level at 186.10. A further resistance level may holdings at 188.74. The Relative Strength Index (RSI) on the 14-day chart is 40.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.73%. Stochastics %K at 16.65% indicates the stock is a buying.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2024-10-15, dropping by -0.6 million shares to a total of 3.07 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 3.67 million shares. There was a decline of -19.58%, which implies that there is a negative sentiment for the stock.
